<th id="grzca"></th>
<b id="grzca"><menuitem id="grzca"></menuitem></b>

<th id="grzca"></th>
<strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    全國(guó)服務(wù)咨詢熱線:

    18438616290

    Products產(chǎn)品中心
    首頁(yè) > 產(chǎn)品中心 > 生化試劑 > 小分子化合物 > abs47027899AF 353 865305-30-2

    AF 353 865305-30-2

    簡(jiǎn)要描述:AF 353 865305-30-2
    AF-353 is a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist, inhibits human and rat P2X3 (pIC50= 8.0).

    • 產(chǎn)品型號(hào):abs47027899
    • 廠商性質(zhì):生產(chǎn)廠家
    • 更新時(shí)間:2026-01-06
    • 訪  問(wèn)  量:723

    詳細(xì)介紹

    品牌absinCAS865305-30-2
    分子式C14H17IN4O2純度98%
    分子量400.21貨號(hào)abs47027899
    規(guī)格5mg供貨周期現(xiàn)貨
    主要用途is a novel, potent應(yīng)用領(lǐng)域化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合

    AF 353 865305-30-2

    產(chǎn)品描述
    描述
    AF-353 is a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist, inhibits human and rat P2X3 (pIC50= 8.0).
    純度
    98%
    儲(chǔ)存/保存方法
    Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
    基本信息
    別名
    AF 353;Ro-4
    可溶性/溶解性
    DMSO : 100 mg/mL (249.87 mM; Need ultrasonic)
    生物活性
    靶點(diǎn)
    P2X3
    In vitro(體外研究)
    AF-353 (Ro-4) is a highly potent inhibitor of α,β-meATP-evoked intracellular calcium flux in cell lines expressing recombinant rat and human P2X3 and human P2X2/3 channels.
    AF-353 (Ro-4) also blocks human P2X2/3 channel function with marginally reduced potency with a p50 of 7.3.
    In vivo(體內(nèi)研究)
    AF-353 (Ro-4) does not compromise oxygen levels or cardiac function.
    AF-353 (Ro-4) (10 mg/kg, 20 mg/kg; i.v.; for 4-6 hours) inhibits the purinergic response in both normal and spinal cord-injured (SCI) rats.
    AF-353 (Ro-4) (10 mg/kg, 20 mg/kg; i.v.; for 4-6 hours) also reduces the inter-contractile interval in normal but not in SCI rats; however, the frequency of non-voiding (NVC) in SCI rats is significantly reduced.
    研究領(lǐng)域
    研究領(lǐng)域
    CancerCancer MetabolismResponse to hypoxia
    MetabolismPathways and ProcessesMetabolism processesHypoxia
    NeuroscienceProcesses
    NeuroscienceNeurotransmissionReceptors / ChannelsLigand-Gated Ion ChannelsP2X Receptors
    Drug DiscoverySmall Molecule DrugLead Compound Discovery
    AF 353 865305-30-2溫馨提示:本產(chǎn)品僅作科研實(shí)驗(yàn)使用,不支持臨床等研究

    產(chǎn)品咨詢

    留言框

    • 產(chǎn)品:

    • 您的單位:

    • 您的姓名:

    • 聯(lián)系電話:

    • 常用郵箱:

    • 省份:

    • 詳細(xì)地址:

    • 補(bǔ)充說(shuō)明:

    • 驗(yàn)證碼:

      請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
    愛(ài)必信(上海)生物科技有限公司
    地址:上海市浦東新區(qū)新浩路58號(hào)申江科創(chuàng)園18棟
    傳真:
    關(guān)注我們
    歡迎您關(guān)注我們的微信公眾號(hào)了解更多信息:
    歡迎您關(guān)注我們的微信公眾號(hào)
    了解更多信息
    <th id="grzca"></th>
    <b id="grzca"><menuitem id="grzca"></menuitem></b>

    <th id="grzca"></th>
    <strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    爱爱黄色视频 | 欧美北条麻妃在线 | 欧美国家一级a片 | 五月婷婷看看色色 | 中文字幕乱 |